Skip to content

Talus Bio

YC S21 · Active · Discovering drugs that target the DNA regulome

Competitors

Adjacent

Also from S21

All of S21

About Talus Bio

We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.

YC batch
S21 · Summer 2021
Status, per YC
Active
Category
Other
Team size
16
Location
Seattle, WA, USA
Checked
1h ago

YC tags: Biotech, Genomics, Drug discovery

Talus Bio in S21: 391 companies, 34% AI

Talus Bio: questions

Which YC batch was Talus Bio in?

Talus Bio was in Y Combinator's Summer 2021 batch (S21).

Is Talus Bio still active?

Y Combinator lists Talus Bio as active.

Where is Talus Bio based?

Talus Bio lists Seattle, WA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.